1. 107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results. (25th November 2018) Authors: Kagawa, Y; Satake, H; Kato, T; Oba, K; Yasui, H; Nakamura, M; Watanabe, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Junichi, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1111PRisk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer. (23rd October 2018) Authors: Shirasu, H; Yokota, T; Fushiki, K; Inoue, H; Shibata, M; Furuta, M; Kawakami, T; Kawai, S; Hamauchi, S; Todaka, A; Tsushima, T; Machida, N; Yamazaki, K; Fukutomi, A; Onozawa, Y; Yasui, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 208TiPA randomized, phase II, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer. (25th November 2018) Authors: Shitara, K; Bang, Y-J; Sakai, D; Yasui, H; Kawaguchi, Y; Sugihara, M; Saito, K; Dalal, R; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 480PThe safety and efficacy of FOLFOXIRI plus molecular target therapy as a first-line treatment for metastatic colorectal cancer: A multicentre retrospective study. (23rd October 2018) Authors: Ogata, T; Satake, H; Ogata, M; Hatachi, Y; Hamada, M; Yasui, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 535PSafety and effectiveness of oral rivaroxaban for the treatment of venous thromboembolism in cancer patients. (22nd November 2017) Authors: Kondo, Y; Hirabatake, M; Satake, H; Yasui, H; Hashida, T Journal: Annals of oncology Issue: Volume 28(2017)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 606TiPRandomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G. (23rd October 2018) Authors: Kito, Y; Yamada, T; Matsumoto, T; Yasui, H; Murata, K; Makiyama, A; Hara, H; Baba, E; Nishio, K; Yoshimura, K; Hironaka, S; Muro, K; Yamazaki, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease. (28th September 2017) Authors: Kusaka, S; Nishida, A; Takahashi, K; Bamba, S; Yasui, H; Kawahara, M; Inatomi, O; Sugimoto, M; Andoh, A Journal: Clinical and experimental immunology Issue: Volume 191:Number 1(2018:Jan.) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-067Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: A retrospective study. (20th June 2018) Authors: Ogata, T; Satake, H; Ogata, M; Hatachi, Y; Yasui, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-165Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study. (2nd July 2019) Authors: Ogata, M; Satake, H; Ama, Y; Hirabatake, M; Ogata, T; Yasui, H; Hashida, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-233Trifluridine/tipiracil vs regorafenib as salvage-line treatment in patients with metastatic colorectal cancer: A multicenter retrospective study. (20th June 2018) Authors: Kotaka, M; Ogata, M; Ogata, T; Hatachi, Y; Yasui, H; Kato, T; Tsuji, A; Satake, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗